arsenic trioxide has been researched along with Papilledema in 2 studies
*Papilledema: Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Micieli, JA; Paxton, AB | 1 |
| Fabry, U; Galm, O; Osieka, R | 1 |
2 other study(ies) available for arsenic trioxide and Papilledema
| Article | Year |
|---|---|
Diagnosis of Acute Promyelocytic Leukemia After Presentation to Neuro-Ophthalmology.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Ophthalmology; Papilledema; Retrospective Studies; Treatment Outcome; Tretinoin; Young Adult | 2022 |
Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide.
Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Neoplasms; Diplopia; Female; Humans; Leukemia, Promyelocytic, Acute; Oxides; Papilledema; Pseudotumor Cerebri | 2000 |